Class action complaint alleging GRAIL insider fraud resubmitted after dismissal

<p>Following last month&#8217;s dismissal of the securities class action complaint against Illumina Inc. and its former spinoff company, GRAIL, the plaintiffs have refiled an amended complaint, keeping the action alive.&#160; This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and [&#8230;]</p> <p>The post <a href="https://cancerletter.com/clinical/20251031_2/"…